Comparison of idrabiotaparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: the Borealis-Atrial Fibrillation Study-Reference-Cited by-同舟云学术

Comparison of idrabiotaparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: the Borealis-Atrial Fibrillation Study

Published:2014-06 Issue:6 Volume:12 Page:824-830
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

Buller H. R.¹,Halperin J.²,Hankey G. J.³⁴,Pillion G.⁵,Prins M. H.⁶,Raskob G. E.⁷

Affiliation:

1. Department of Vascular Medicine; Academic Medical Center; Amsterdam the Netherlands

2. The Cardiovascular Institute; Mount Sinai Medical Center; New York NY USA

3. School of Medicine and Pharmacology; The University of Western Australia; Perth WA Australia

4. Department of Neurology; Sir Charles Gairdner Hospital; Perth WA Australia

5. Sanofi-Aventis Recherché et Développement; Chilly Mazarin France

6. Department of Epidemiology; Maasticht University Medical Centre; Maastricht the Netherlands

7. The University of Oklahoma Health Sciences Center; Oklahoma city OK USA

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jth.12546/fullpdf

Reference9 articles.

1. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis;Hart;Ann Intern Med,1999

2. Antithrombotic therapy in atrial fibrillation: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy;Singer;Chest,2004

3. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range;Hirsh;Chest,2001

4. Phase III studies on novel oral anticoagulants for stroke prevention in atrial fibrillation: a look beyond the excellent results;Pengo;J Thromb Haemost,2012

5. Comparison of idraparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: a randomised, open-label, non-inferiority trial;The AMADEUS Investigators;The Lancet,2008

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Phenotype Classification of Atrial Fibrillation Patients Using Cluster Analysis and Associations with Trial-Adjudicated Outcomes;Biomedicines;2021-07-20

2. Clinical outcomes associated with kidney function changes in anticoagulated atrial fibrillation patients: An ancillary analysis from the BOREALIS trial;Journal of Arrhythmia;2020-02-06

3. Novel N-acetyl-Glycol-split heparin biotin-conjugates endowed with anti-heparanase activity;European Journal of Medicinal Chemistry;2020-01

4. Anticoagulant heparins;The Heparins;2020

5. Differences in outcomes between oral anticoagulation “new starters” and “switchers” in patients with nonvalvular atrial fibrillation: A pooled analysis of the AMADEUS and BOREALIS trials;Journal of Arrhythmia;2019-11-11